Journal
ISCIENCE
Volume 24, Issue 3, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2021.102189
Keywords
-
Categories
Funding
- Medical Research Council [MR/T002573/1]
- Engineering and Physical Sciences Research Council [EP/R513064/1]
- MRC [MR/T002573/1] Funding Source: UKRI
Ask authors/readers for more resources
Despite the excellent optical properties and biocompatibility shown by some NIR QDs, there are still challenges to overcome in clinical applications. By selectively controlling synthetic methodologies, it is possible to obtain QDs that emit in different wavelength ranges, allowing for superior imaging properties.
Fluorescence imaging has gathered interest over the recent years for its real-time response and high sensitivity. Developing probes for this modality has proven to be a challenge. Quantum dots (QDs) are colloidal nanoparticles that possess unique optical and electronic properties due to quantum confinement effects, whose excellent optical properties make them ideal for fluorescence imaging of biological systems. By selectively controlling the synthetic methodologies it is possible to obtain QDs that emit in the first (650-950 nm) and second (1000-1400 nm) near infra-red (NIR) windows, allowing for superior imaging properties. Despite the excellent optical properties and biocompatibility shown by some NIR QDs, there are still some challenges to overcome to enable there use in clinical applications. In this review, we discuss the latest advances in the application of NIR QDs in preclinical settings, together with the synthetic approaches and material developments that make NIR QDs promising for future biomedical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available